Reuters – France’s Sanofi-Aventis on Sunday publicly disclosed its $18.5 billion, $69-per-share cash offer for Genzyme Corp in a bid to rouse shareholders after failing to engage the U.S. biotechnology company in merger talks.
Read the original post:
Sanofi makes $18.5 billion Genzyme offer public
(Reuters)



Recent Comments